US entrepreneurs and investors in the life sciences and health sector are invited to join the Global Investor Forum in Boston on April 17th 2019. Connect with the buzzing life sciences and health industry in the Netherlands and find out about available opportunities. The forum will be held on the historic ship Clipper Stad Amsterdam.
Whether you are a company looking for investors, an investor looking for opportunities, or just want to know everything about the life sciences sector in the Netherlands, don't miss this boat!
The Global Investor Forum in collaboration with Invest in Holland welcomes you aboard the historic Clipper Stad Amsterdam on 17 April, docked at the Fan Pier Boston.
The Netherlands has a world-leading life sciences and health ecosystem. This innovative community has produced many new biotech companies in recent years and offers an excellent foothold for US companies wanting to expand into Europe. The European Medicines Agency's (EMA) relocation to the Netherlands will boost the life sciences ecosystem even further.
The Global Investor Forum creates a powerful network of leading biomed entrepreneurs, formal and informal investors, key medical opinion leaders and company executives for enabling the next steps of biomed and Healthcare ventures. The forum provides an excellent opportunity to meet each other, learn from real-life business cases and form connections. The programme will conclude with a networking reception in an exclusive setting. So, trim your sails, know your ropes and take full advantage of the wind in the sails of the life sciences sector in the Netherlands.
Global Investor Forum Life Sciences and Health
Wednesday 17 April 2019
Aboard the historic ship Clipper Stad Amsterdam
docked at Fan Pier
Boston, 1 Marina Park Drive, MA 02210
The clipper has a maximum capacity, so space is limited. Secure your seat as soon as possible.
09:30 - 10:00 - Welcome aboard the clipper Stad Amsterdam!
10:00 - 10:15 - Opening Global Investor Forum - Marianne van der Steen, Founder Global Investor Forum
10:15 - 11:00 - Interactive panel discussion "The European Medicines Agency in the Netherlands, an opportunity for Life Sciences", moderated by Hans Schikan, board member Top Sector Life Sciences & Health, the Netherlands; Yvonne Greenstreet, Chief Operating Officer Alnylam Phamaceuticals; Travis McCready, President and CEO of the Massachusetts Life Sciences Center; David Meeker, CEO at KSQ Therapeutics and former CEO Genzyme; and Henk Schuring, Vice President Head of Rare Nephrology at Sanofi Genzyme
11:00 - 11:30 - Going Dutch, the strength of public private partnerships, Prof. Dr. Marianne van der Steen, Director RegMed XB
11:30 - 13:00 - Walking the ship, networking & lunch break
13:00 - 13:30 - Empowering Personalized Medicine & Health Reseach by Prof. Dr. Hen-Jan Guchelaar, program leader research program 'Personalized Therapeutics' and head Clinical Pharmacy & Toxicology LUMC
13:30 - 14:00 - Pioneering Medical Imaging by Prof. dr. Guus van Dongen, director of VUmc Imaging Center Amsterdam
14:00 - 14:30 - Fire side chat with testimonials from Life Sciences companies doing business in the Netherlands: Bernard Sixt, CEO at Edinburgh Molecular Imaging and Berndt Modig, CEO Pharvaris
14:30 - 14:45 - Coffee break
14:45 - 15:00 - Welcome to the Capital Network: Prof. Dr. Marianne van de Steen, Founding Director Global Investor Forum and Global Scale-UP Program
15:00 - 17:15 - Pitch session of selected Dutch companies with The Capital Network Investors Shark Tank Style
17:15 - 17:30 - Closing remarks: Hans Schikan, Board membe Topsector Life Sciences & Health, The Netherlands
17:30 - 20:00 - Networking reception
The official programme will be sent with your confirmation. To apply / for questions please contact email@example.com